Amphastar Pharma (AMPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Sales | 95,921 | 83,431 | 85,806 | 84,688 | 83,383 |
| Cost of Goods | 59,089 | 46,923 | 52,629 | 47,865 | 50,002 |
| Gross Profit | 36,832 | 36,508 | 33,177 | 36,823 | 33,381 |
| Operating Expenses | 34,042 | 33,914 | 36,728 | 30,208 | 33,627 |
| Operating Income | 2,879 | 3,517 | -2,922 | 7,480 | -244 |
| Interest Expense | 88 | 175 | 35 | 76 | 43 |
| Other Income | -9,533 | 3,736 | 1,453 | -1,599 | 1,473 |
| Pre-tax Income | -6,742 | 7,078 | -1,504 | 5,805 | 1,186 |
| Income Tax | -950 | 2,285 | -75 | 2,280 | 431 |
| Net Income Continuous | -5,792 | 4,793 | -1,429 | 3,525 | 755 |
| Minority Interests | 481 | 874 | -1,237 | -424 | 1,781 |
| Net Income | $-6,273 | $3,919 | $-192 | $3,949 | $-1,026 |
| EPS Basic Total Ops | -0.14 | 0.08 | 0.00 | 0.09 | -0.02 |
| EPS Basic Continuous Ops | -0.12 | 0.10 | -0.03 | 0.08 | 0.02 |
| EPS Diluted Total Ops | -0.13 | 0.08 | 0.00 | 0.08 | -0.03 |
| EPS Diluted Continuous Ops | -0.12 | 0.10 | -0.03 | 0.07 | 0.01 |
| EBITDA(a) | $8,689 | $9,194 | $2,144 | $12,454 | $4,562 |